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ABSTRACT
Objective: To determine the sociodemographic, clinical characteristics, and outcomes of inﬂuenza pneumonia patients in
tertiary care hospital, Karachi Pakistan.
Study Design: A cross-sectional study.
Place and Duration of Study: The Aga Khan University Hospital Karachi Pakistan from January 2013 to December 2018.
Methodology: All adult patients who were older than 18 years and suspected to have viral pneumonia were included in the
study. Data were abstracted on 105 patients and were entered on preformed proforma after reviewing the ﬁles of patients.
Results: Ninety-four (89.5%) patients were inﬂuenza positive and 15.2% (n=16) had been vaccinated. Around 92.4% (n=97),
81.9% (n=86) and 61.9% (n=65) patients had cough, fever and shortness of breath, respectively; and 63.8% (n=67), 16.2%
(n=17), and 2.9% (n=3) patients had consolidation, nodules, and cavitation, respectively. Almost 91.4% (n=96) patients were
given treatment and discharged home; however, 7.6% (n=8) died. Procalcitonin, creatinine, HCO3 , lactate, and bilirubin level
were increased in 2nd group (mortality group) after 48 hours; however, the results were only signiﬁcant for HCO3 (p = 0.035).
Conclusion: Inﬂuenza pneumonia is very common in our population and older people are more likely to be aﬀected by this
disease. Patients can be prevented from adverse outcomes and complications, if diagnosed and treated in time.
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INTRODUCTION
Community-acquired pneumonia (CAP) is a signiﬁcant world1
wide health problem. Viral pathogens such as inﬂuenza and
rhinovirus have been implicated as causes in an estimated one2,3
third of CAP cases. Globally, pneumonia is the most common
infectious cause of death, the fourth most common cause of
death overall, and the second leading cause of life years lost.4
There are globally 3.5 million deaths from community-acquired
pneumonia annually.5 The inﬂuenza pandemic in 2009 had a
strong eﬀect on clinical practice, and was the leading complica6
tion of inﬂuenza virus infection.
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Among viral pneumonia, inﬂuenza pneumonia is the most
common, both in adults and paediatric age groups.7,8 Superadded bacterial pneumonia on the background of inﬂuenza
pneumonia has been an established phenomenon and is associ9
ated with worse outcomes.
There has been a substantial rise in the incidence of inﬂuenza
10
pneumonia during the winter season in Pakistan. The high
population density, proximity to animal reservoirs, and lack of
awareness and access to inﬂuenza immunisation, has put our
population to a substantial risk of inﬂuenza pneumonia. There
has been no study done in Pakistan to delineate the clinical
course of inﬂuenza pneumonia in our population. Studies done
in other low to middle-income countries have demonstrated a
varied demographic pattern and mortality as compared to high4
-income countries. Hence, this study will determine in detail
the pattern of disease (inﬂuenza pneumonia), its hospital
course and mortality.
The objective of this study was to determine the clinical characteristics including symptoms, laboratory ﬁndings, chest imaging,
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and mortality in inﬂuenza pneumonia patients admitted at a
tertiary care hospital in Karachi.

METHODOLOGY
A cross-sectional study was conducted in the inpatient setting of
the Aga Khan University Hospital, Karachi, Pakistan by using inpatient data from January 2013 to December 2018.
’

All patients medical records were identiﬁed through searching
the medical records with diagnosis of suspected inﬂuenza pneumonia, using consecutive sampling technique. All adult
patients’, who were older than 18 years, suspected to have viral
pneumonia on presentation, and underwent inﬂuenza PCR
testing after admission to conﬁrm the status of infection, were
included. Patients who developed hospital-acquired pneumonia,
deﬁned as lung inﬁltrates and symptoms of pneumonia after 48
hours of admission, had lung inﬁltrates clinically consistent with
cardiogenic pulmonary edema, and improved after diuretics
therapy, were excluded from the study.
Pneumonia was deﬁned as any patient having a new inﬁltrate on
the chest X-Ray with any one of the following characteristics:
body temperature ≥38° Celsius, cough, WBC count ≥11000/dL or
<4000/dL, and need for supplemental oxygen; which must be of
less than two weeks’ duration. Patients with clinical features of
pneumonia, whose nasopharyngeal or sputum samples for H1N1
PCR were sent within 24 hours of ER presentation, were classiﬁed
as having presumed pneumonia. If PCR results were positive in
nasopharyngeal or sputum samples, then those cases were classiﬁed as conﬁrmed inﬂuenza pneumonia.
Data were extracted on 105 patients and were entered on
preformed proforma after reviewing the ﬁles. No patient identiﬁers were recorded to protect patients’ privacy. Data were
collected on patients’ demographics such as age and gender,
patients’ history of comorbid such as the presence of diabetes
mellitus, asthma, malignancy, tuberculosis, HIV and any other
comorbidity. Data were collected on patients’ symptoms along
with symptom’s duration, X-ray ﬁndings, inﬂuenza vaccination
status, clinical laboratory investigations at the time of admission
and 48 hours after admission, to ascertain the progress of the
patients. Complications were noted, such as cardiomyopathy,
pneumothorax, acute kidney injury, and any other hospital-acquired infections; and outcome of the patient whether the
patient was discharged or died.

Frequencies and proportions were calculate to describe the
characteristics of the study population for the categorical variables such as gender, presence of diabetes or asthma, etc. Histograms superimposed with normal curves to check the normality
of continuous variables were used. Mean and standard deviations were determined for normally distributed continuous variables (age); otherwise, median and interquartile (IQR) were
determined, if data was skewed. Level of signiﬁcance or alpha
was kept as 5% for this study. A new parameter was calculated
and labelled as diﬀerence in labortary parameter by
subtratcting value of labortary parameters at the time of admission and after 48 hours of admission. This was followed by

assessing the association between diﬀerence in the laboratory
parameter and clinical outcome, i.e. discharge and death.
Mann-Whitney U-test was used to compare diﬀerences in the
laboratory parameter and clinical outcome and p-value of less
than 0.05 was used a cut-oﬀ for signiﬁcant results. SPSS version
23.0 was used to analyse the data. This study was reviewed and
approved by the Ethics Review Committees of the Aga Khan
University.

RESULTS
A total of 105 patients met inclusion criteria, who were initially
admitted as suspected inﬂuenza patients. Around 89.5%
(n=94) of all suspected cases were later conﬁrmed to have
inﬂuenza pneumonia. The mean age of the patients admitted to
the hospital was 54.20±18.54 years. The most common comorbidity was diabetes, which was found in 40.0% (n=42) patients,
while 16.2% (n=17) had asthma, 12.4% (n=13) had COPD, and
8.6% had chronic kidney disease (n=9, Table I).
Table I: Sociodemographic and clinical characteristics of patients
presenting in a tertiary care hospital in Karachi (n=105).

Age (years) Mean (SD)

54.20 (18.54)

Age of patient (years):
≤50 years
>50 years

36 (34.3)
69 (65.7)

Gender:
Males
Females

39 (37.1)
66(62.9)

Diabetes mellitus:
Yes
No

42 (40.0)
63(60.0)

HIV:
Yes
No

1 (1.0)
104 (99.0)

Malignancy:
Yes
No

1 (1.0)
104 (99.0)

Asthma:
Yes
No

17 (16.2)
88 (83.8)

COPD:
Yes
No

13 (12.4)
92 (87.6)

Interstitial lung disease:
Yes
No

3 (2.9)
102 (97.1)

Transplant history:
Yes
No

1 (1.0)
104 (99.0)

Chronic kidney disease:
Yes
No

9 (8.6)
96 (91.4)

Tuberculosis:
Yes
No

1 (1.0)
104 (99.0)

Inﬂuenza vaccination:
Yes
No

16 (15.2)
89 (84.8)
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Table II: Clinical proﬁle of patients presenting in a tertiary care hospital
in Karachi (n=105).
Clinical parameters

Median (IQR)

Leucocyte counts
Neutrophils
Lymphocytes
Hemoglobin
C-Reactive protein
Sodium
Potassium
Chloride
Bicarbonate
Bilirubin levels
Partial pressure of O2
Partial pressure of CO2

11.0 (7.3 – 18.0)
80.0 (70.0 – 88.0)
11.0 (8.0 – 16.2)
12.3 (11.0 – 13.5)
3.1 (2.0 – 12.4)
134.0 (129.0 – 137.0)
3.7 (3.2 - 4.1)
99.0 (94.0 -105.0)
22.0 (16.2 – 25.8)
2.0 (1.1 – 2.0)
62.0 (2.0– 79.0)
25.0 (2.0 – 36.0)

Laboratory parameters were compared of the patient on admission and after 48 hours of admission were between two groups
i.e. one group who was discharged (survival group) and one
group of patients who unfortunately could not survive in
hospital (mortality group). Overall, procalcitonin, creatinine,
HCO3, lactate and bilirubin level increased in 2nd group (mortality group) after 48 hours, however, the results were only
signiﬁcant for HCO3 with p value 0.035 (Table III).

Table III: Laboratory parameters of patients on admission and after 48
hours of admission between two groups (n=105).

Leukocyte diﬀerence
Neutrophil diﬀerence

Discharge
2 (-0.6 – 7.1)
10 (-1 – 66.2)

Death
3.2 (0.2 – 11.4)
-0.9 (-9.6 – 77.9)

p-value
0.539
0.700

Lymphocyte diﬀerence

5 (-3.3 – 10)

6.7 (2.7 – 11.4)

0.208

CRP diﬀerence

0 (0 – 5.3)

0 (0 - 9.9)

0.947

Procalcitonin diﬀerence

0 (-1.2 – 0)

-0.05 (-1.9 – 0.12)

0.249

Creatinine
Sodium
HCO3 diﬀerence
Bilirubin
Lactate
FiO2
ALT
pH

0 (-0.7 – 0.3)
-1 (-7 – 130)
0.2 (-3 – 16)
0 (0 – 0)
0 (0 - 0.5)
0 (0 – 27)
0 (0 – 20)
0 (0 – 5.4)

-0.1 (-1.6 – 0.9)
-5 (-14 – 0)
-2.8 (-11.8 – 0.2)
-0.5 (-1.6 – 0.9)
0.2 (-2.7 – 1.7)
0 (0 – 37.5)
25 (-14 – 143.5)
0.03 (-0.1 – 0.2)

0.631
0.131
0.035
0.258
0.994
0.762
0.186
0.768

Laboratory parameter

Ninety-seven (92.4%) patients had cough with a mean duration
of around 4.23 ± 2.48 days. Similarly, 81.9 % (n=86) patients
had fever with a median duration of around 3.89 ± 2.4 days.
Around two-thirds of the patients (61.9%, n=65) had shortness
of breath with a median duration of 3.0 days. With respect to the
chest X-ray ﬁndings, it was found that 63.8% (n=67) patients
had consolidation, 16.2% (n=17) had nodules, 7.6% (n=8) had
ground-glass opacity, and 14.3% (n=15) had pleural eﬀusion.
None of the inﬂuenza positive patients had any cavitation on
chest X-ray.
Table II shows the clinical proﬁle of patients presenting to a
tertiary care hospital in Karachi. The data found that median hemoglobin was 12.3 g/l (11.0 – 13.5), median C-reactive protein was
3.1 mg/dl (2.0 – 12.4), median sodium 134.0 mol/l (129.0 – 137.0),
median potassium 3.7 (3.2 - 4.1) mmol/l, median bicarbonate 22.0
mmol/l (16.2 – 25.8), mean WBC 12.8 ± 7.4, and median bilirubin
levels 2.0 mg/dl (1.1 – 2.0).

Out of inﬂuenza-positive patients, 45.7% (n=43) needed non-invasive ventilation BiPAP and 19 (22% of all positive cases) of
them needed ICU admission for invasive ventilation. Among
16% (n=15) resuscitation code was changed from full to DNR
due to comorbid and worsening conditions. However, around
13.3% (n=14) of the patients developed hemoptysis, 25.7%
(n=27) had non ST-segment elevation myocardial infarction,
11.4% (n=12) developed cardiomyopathy, 39.4% (n=37) developed acute kidney injury. A very small proportion of patients
captured nosocomial infections by methicillin-resistant staphylococcus or carbapenem-resistant enterobacteriaceae and
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median length of stay was 3 days. Only 14 out of 94 inﬂuenza-positive patients had received inﬂuenza vaccination. Only 1 out
of 14 (7%), while 80 patients did not receive the vaccine, 8 out of
this group expired (10%).

DISCUSSION
This study found that around 89.5% patients admitted in the
hospital were diagnosed positive for inﬂuenza pneumonia and
most of those patients were older males and diabetic. Patients
older than 50 years were more likely to have inﬂuenza when
compared to their counterparts. In addition, it was also found
that less than a quarter of patients had been vaccinated for
inﬂuenza vaccine. This study also revealed that most of the
patients presented with cough, fever, and shortness of breath;
however, very few had chest pain of shorter duration. The
majority of the patients were found to have consolidation on the
chest X-ray and very few had nodules or capitations. Almost all
patients were discharged home after being treated in the
hospital with 8% of mortality in inﬂuenza-positive patients.
This study ﬁndings are comparable with many studies conducted
in São Paulo, which found that most of the patients had nodules,
ground-glass opacities and pleural eﬀusion on the chest X-ray.11
The same study also found that the most common symptoms
among patients were cough, fever, and shortness of breath, which
are consistent with our study ﬁndings.11
Our study ﬁndings diﬀer with few studies that found a longer
length of stay and more adverse outcomes, such as mortality
among those who had pneumonia.12,13 These diﬀerences could be
due to the severity of the condition. Patients in our study were
admitted in the ward with less severe symptoms when compared
to other studies where patients were admitted in the ICU with
more severe symptoms, thus contradicting this study ﬁndings.14,15
This study has some potential caveats that need to be addressed
in the future. One of the main potential limitations of the study is
the design, which was a cross-sectional study and the authors
could not determine the temporal precedence between various
factors and outcomes. The sample size was only 105, which was
not suﬃcient to adequately power our study for exploring the clinical and sociodemographic determinants. Lastly, this study was
not a follow-up study; therefore, we do not know about the
outcomes of the patients after being discharged from the hospital.

CONCLUSION
Inﬂuenza pneumonia is very common in our population and
older people are more likely to be aﬀected by this disease. This
study demonstrated that patients can be saved from adverse
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outcomes and complications, if diagnosed and treated
promptly. However, the authors recommend undertaking longitudinal primary epidemiological studies to determine the long
term outcomes among these patients, and to explore their
sociodemographic and clinical characteristics with the adequately powered study.
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